Document is current
Any future updates will be listed below
-
Authors
Viirre, Erik
Sittlington, Julie
Wing, David
Price, Ruth
Logue, Caomhan
Moreno, Daniel
Ledford-Mills, Jeff
Knott, Cynthia
le Roux, Carel W.
Grieve, David
Watson, Sinead
McKeown, Jason
McGeoch, Paul D.
-
Funding
Funding for this research was provided by:
Neurovalens Ltd
- License Information
-
More Information
Article History
Received: 4 October 2024
Accepted: 3 March 2025
First Online: 13 March 2025
Declarations
:
: PDM is named as an inventor on various patents issued to the University of California that pertain to using vestibular stimulation to modify body mass composition. PDM and JM are co-founders of Neurovalens Ltd which is a company commercially developing vestibular stimulation as a treatment modality for a range of conditions including obesity. JM is CEO of Neurovalens and PDM is a director. SW is an employee of Neurovalens. No one in the Neurovalens team had any direct interaction with the clinical trial participants, nor were they involved in any aspects of trial execution, such as sample collection or measuring clinical outcomes. No other authors have competing interests.
